February 2012 Drug Update Information - Pharmacy Benefits ...

More documents

Recommendations

Info

20 mg, 30 count (NDC 00093-0174-56) Reason for the Shortage Apotex relaunched leflunomide tablets in August 2011. Teva had leflunomide tablets on shortage due to unavailability of raw material. Sandoz had leflunomide tablets on shortage due to increased demandd and delay of raw material. Article link: http://www.ashp.org/DrugShortages/Current/Bulletin.aspx?id=711 Source: http://www.a ashp.org Furosemide Injection February 1, 2012 Products Affected - Description Furosemide Injection, 10 mg/mL, Hospira 4 mL vial (NDC 00409-6102-04) 2 mL Carpuject syringe (NDC 00409-1275-32) - discontinued Furosemide Injection, 10 mg/mL, American Regent 4 mL vial (NDC 00517-5704-25) 10 mL vial (NDC 00517-5710-25) Furosemide Injection, 10 mg/mL, APP1 4 mL vial (NDC 63323-0280-04) Reason for the Shortage APP has furosemide injection on shortage due to increased demand for the product. American Regent had temporarily suspendedd manufacture of most drug products including furosemide in April, 2011. American Regent resumed manufacturing in Shirley, New York in early-May, 2011. Hospira has furosemide on shortage due to manufacturin ng delays. Wockhardt has discontinued all furosemide injection presentations. Article link: http://www.ashp.org/DrugShortages/Current/Bulletin.aspx?id=636 Source: http://www.a ashp.org Diclofenac 1% Gel February 1, 2012 Products Affected - Description Voltaren gel, Endo 100 gram, 3 count (NDC 63481-0684-03) 100 gram, 5 count (NDC 63481-0684-05) Reason for the Shortage Endo is the sole supplier of Voltaren gel. Endo could not provide a reason for the shortage. This shortage is not affecting Pennsaid 1.5% solution, another topical diclofenacc preparation for treating osteoarthritis s symptoms. Article link: http://www.ashp.org/DrugShortages/Current/Bulletin.aspx?id=889 Source: http://www.a ashp.org Thiothixene Capsules February 2, 2012 Products Affected - Description Thiothixene capsules, Sandoz 2 mg capsules, 100 count (NDC 00781-2227-01) - discontinued 5 mg capsules, 100 count (NDC 00781-2228-01) - discontinued 10 mg capsules, 100 count (NDC 00781-2229-01) - discontinued 46
Thiothixene capsules, Mylan 2 mg capsules, 1000 count (NDC 00378-2002-10) 5 mg capsules, 1000 count (NDC 00378-3005-10) 10 mg capsules, 10000 count (NDC 00378-5010-10) - discontinued Navane capsules, Pfizer 2 mg capsules, 100 count (NDC 00049-8720-66) - discontinued 10 mg capsules, 100 count (NDC 00049-5740-66) - discontinued 5 mg capsules, 100 count (NDC 00049-5730-66) - discontinued 20 mg capsules, 100 count (NDC 00049-5770-66) - discontinued Reason for the Shortage Sandoz states the shortage is due to a delay in acquiring raw materials. Sandoz has temporarily discontinued the 2 mg, 5 mg, andd 10 mg presentations. Pfizer discontinued Navane (thiothixene) 2 mg, 10 mg, and 20 mg presentations in the fall of 2011. The Navane 5 mg presentation was discontinued previously. Mylan could not provide a reason for the shortage. Mylan discontinued thiothixene 10 mg 1000 count capsules in the first half of 2011. Article link: http://www.ashp.org/DrugShortages/Current/Bulletin.aspx?id=835 Source: http://www.a ashp.org Amphetamine Mixed Salts, Immediate-Release Tablets February 2, 2012 Products Affected - Description Amphetamine mixed salts immediate-releasee tablets, Teva 5 mg tablets, 100 count (NDC 00555-0971-02) 7.5 mg tablets, 100 count (NDC 00555-0775-02) 10 mg tablets, 100 count (NDC 00555-0972- -02) 12.5 mg tablets, 100 count (NDC 00555-0776-02) 15 mg tablets, 100 count (NDC 00555-0777- -02) 20 mg tablets, 100 count (NDC 00555-0973- -02) 30 mg tablets, 100 count (NDC 00555-0974- -02) Adderall, Teva 5 mg tablets, 100 count (NDC 00555-0762-02) 7.5 mg tablets, 100 count (NDC 00555-0763-02) 10 mg tablets, 100 count (NDC 00555-0764- -02) 12.5 mg tablets, 100 count (NDC 00555-0765-02) 15 mg tablets, 100 count (NDC 00555-0766- -02) 20 mg tablets, 100 count (NDC 00555-0767- -02) 30 mg tablets, 100 count (NDC 00555-0764- -02) Amphetamine mixed salts immediate-releasee tablets, Sandoz 5 mg tablets, 100 count (NDC 00185-0084-01) 10 mg tablets, 100 count (NDC 00185-0111- -01) 20 mg tablets, 100 count (NDC 00185-0401- -01) 30 mg tablets, 100 count (NDC 00185-0404- -01) Amphetamine mixed salts immediate-releasee tablets, CorePharma 5 mg tablets, 100 count (NDC 64720-0130-10) 10 mg tablets, 100 count (NDC 64720-0132- -10) 20 mg tablets, 100 count (NDC 64720-0135- -10) 30 mg tablets, 100 count (NDC 64720-0136- -10) Reason for the Shortage Teva states the shortage is due to DEA quota restrictions. 47
Page 1 and 2: February 2012 Drug Information Upda
Page 3 and 4: GENERIC DRUG NAME GENERIC APPROVAL
Page 5 and 6: CICLOPIROX/ TOPICAL PEDIPIROX-4 New
Page 7 and 8: [Posted 01/09/2012] ISSUE: Novartis
Page 9 and 10: Studies Article Link: http://www.fd
Page 11 and 12: the use of XARELTO® (rivaroxaban),
Page 13 and 14: acteria. The Food and Drug Administ
Page 15 and 16: Statins raise risk of Type 2 diabet
Page 17 and 18: The Million Women Study, a U.K. pro
Page 19 and 20: Azithromycin 250 mg tablets, 1 card
Page 21 and 22: RECALLING FIRM/MANUFACTURE Recallin
Page 23 and 24: Recalling Firm: Pfizer Us Pharmaceu
Page 25 and 26: 250 mg, 100 count (NDC 00591-3969-0
Page 27 and 28: Sandoz states the shortage is due t
Page 29 and 30: 5 mL ampule (NDC 10019-0033-72) 20
Page 31 and 32: Article Link: http://www.ashp.org/D
Page 33 and 34: Lidocaine 2% (with epinephrine 1:10
Page 35 and 36: Source: http://www.a ashp.org Halop
Page 37 and 38: ecome unavailable for an extended t
Page 39 and 40: American Regent resumed manufacturi
Page 41 and 42: Trandate tablets, Prometheus 100 mg
Page 43 and 44: Article link: http://www.ashp.org/D
Page 45: Bedford Laboratories has multiple p
Page 49 and 50: 20 mL vials (NDC 10019-0905-03) - d
Page 51 and 52: 500 mg extended release, 500 count
Page 53 and 54: 1 mg/mL, 4 mL vial (NDC 25021-0781-
Page 55 and 56: West-Ward states the shortage is du
Page 57 and 58: 150 mL bottle (NDC 63304-0954-02) C

February 2012 Drug Update Information - Pharmacy Benefits ...

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?